2026-04-13T06:53:37Zhttps://recercat.cat/oai/requestoai:recercat.cat:2445/1835902025-12-05T13:10:48Zcom_2072_1057col_2072_478798col_2072_478917
RECERCAT
author
Lladó Garriga, Laura
author
Iborra Ortega, Elena
author
Ramos Rubio, Emilio
author
Sabé, Nuria
author
Cachero, Alba
author
Fabregat Prous, Joan
2022-02-28T17:13:11Z2022-02-28T17:13:11Z2020-09-012022-02-28T17:13:11Z
Liver transplantation (LT) after neoadjuvant chemoradiotherapy in patients with unresectable hilar cholangiocarcinoma (HC) is an accepted treatment strategy [1]. Neoadjuvant therapy is associated with an increased risk of arterial and portal complications after LT [1,2]. In most cases, radiation therapy makes the use of the native hepatic artery inadvisable, and an aortic anastomosis is needed, either with or without a graft [2]. The development of a mycotic pseudoaneurysm after LT is a rare complication that is associated with a high incidence of graft failure and mortality. Radiotherapy, local infections and the use of grafts are known risk factors for the development of a mycotic pseudoaneurysm, which is always challenging to manage [3].
cc-by-nc-nd (c) Elsevier B.V., 2020 https://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess
Arteritis
Càncer de fetge
Trasplantament hepàtic
Derivació cardiopulmonar
Arteritis
Liver cancer
Hepatic transplantation
Cardiopulmonary bypass
Extra-anatomic aortic bypass for the treatment of a mycotic pseudoaneurysm after liver transplantation for hilar cholangiocarcinoma
info:eu-repo/semantics/article info:eu-repo/semantics/acceptedVersion